BOSTON, Jan. 2, 2019 /PRNewswire/ -- Ginkgo Bioworks, the organism company, today announced that Jason Kelly, Ginkgo Bioworks CEO and co-founder, will present at the 37th Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2019 at 9:30 AM Pacific Time at the Westin
Ginkgo recently announced the opening of Bioworks4, the first automated foundry for genetically engineering mammalian cells used in the discovery and manufacturing of therapeutics. In his presentation, Kelly will discuss Ginkgo's foundry approach and the potential for synthetic biology to accelerate innovation in pharma.
About Ginkgo Bioworks
Headquartered in Boston, Ginkgo Bioworks uses the most advanced technology on the planet biology to grow products instead of manufacturing them. The company's technology platform is bringing biotechnology into consumer goods markets, enabling fragrance, cosmetic, nutrition, food, agriculture and pharmaceuticals to make better products. For more information, visit www.ginkgobioworks.com.
Media:Bateman GroupJordyn Lee, firstname.lastname@example.org
Investors:Argot PartnersMaeve Conneighton, email@example.com
View original content:http://www.prnewswire.com/news-releases/ginkgo-bioworks-ceo-to-present-at-the-37th-annual-jp-morgan-healthcare-conference-300769965.html
SOURCE Ginkgo Bioworks
Subscribe to our Free Newsletters!